Core Scientific, Inc/tx Form 4 insider transactions

Core Scientific's Chief Legal and Administrative Officer, Todd DuChene, sold 25,000 shares of common stock at an average price of $17.0968.

Core Scientific director Yadin Rozov acquired 195,000 shares of common stock and 195,000 Tranche 2 warrants at a price of $0.01 per share.

Denise Marie Brucia Sterling, CFO of Core Scientific, reports the acquisition of 318,613 shares of common stock via a restricted stock unit (RSU) grant and the disposal of 440,830 shares on September 5, 2024.

Director Jarrod M. Patten of Core Scientific, Inc. executed a transaction involving the acquisition and disposal of common stock on September 13, 2024.

Director Jarrod M Patten purchased 2,100 shares of Core Scientific, Inc. (CORZ) at $10.1 per share on September 11, 2024, increasing his direct holdings to 297,760 shares.

Director Jarrod M Patten of Core Scientific, Inc. purchased 2,100 shares of common stock at $9.90 per share on September 10, 2024, increasing his direct holdings to 295,660 shares.

Director Eric Stanton Weiss purchased 5,000 shares of Core Scientific, Inc. at $9.21 per share on September 9, 2024.

Director Jarrod M Patten purchased 7,800 shares of Core Scientific, Inc. (CORZ) at $9.28 per share on September 4, 2024, increasing his direct holdings to 293,560 shares.

Director Jarrod M. Patten of Core Scientific, Inc. purchased 5,021 shares of common stock at an average price of $9.6786 on September 3, 2024.

Director Jarrod M Patten of Core Scientific, Inc. recently acquired 1,500 shares of common stock at $9.95 per share, increasing his total holdings to 280,739 shares.

Director Jarrod M Patten of Core Scientific, Inc. purchased 4,000 shares of common stock at $9.7 per share on August 28, 2024.

Director Jordan Levy of Core Scientific, Inc. purchased 48,700 shares of common stock at an average price of $10.1957 on August 20, 2024.

CEO Adam Taylor Sullivan acquired shares and warrants of Core Scientific, Inc. in a transaction dated August 16, 2024.

Core Scientific's CFO, Denise Brucia Sterling, sold 8,752 shares of common stock on August 16, 2024, to satisfy tax obligations related to vesting restricted stock units.

Todd M. DuChene, Chief Legal and Administrative Officer of Core Scientific, sold 11,582 shares of common stock to satisfy tax obligations upon the vesting of restricted stock units.

Todd M. Duchene, Chief Legal and Administrative Officer of Core Scientific, Inc., reports the acquisition of common stock through restricted stock units (RSUs) and performance-based RSUs (PSUs).

Todd M. Duchene, Chief Legal and Administrative Officer of Core Scientific, sold 7,321 shares of common stock to satisfy tax obligations related to vesting restricted stock units.

Adam Sullivan, CEO of Core Scientific, reports the acquisition of common stock and grants of restricted stock units (RSUs) and performance-based RSUs (PSUs).

Todd DuChene, Chief Legal and Administrative Officer of Core Scientific, sold shares of common stock to satisfy tax obligations related to vesting restricted stock units.

Director Jarrod M Patten receives restricted stock units from Core Scientific, Inc.

Director Jordan Levy reports acquisition of restricted stock units in Core Scientific, Inc.

Director Todd A. Becker receives restricted stock units from Core Scientific, Inc.

Director Eric Stanton Weiss acquired 175,239 shares of Core Scientific, Inc. through restricted stock unit (RSU) grants.

Director Rozov Yadin reports acquisition of restricted stock units in Core Scientific, Inc.

Director Jeffrey David Booth receives restricted stock units from Core Scientific, Inc.

Director Rozov Yadin reports the acquisition of Tranche 2 Warrants in Core Scientific, Inc.

Core Scientific's CFO, Denise Brucia Sterling, sold 4,261 shares of common stock on May 13, 2024, to satisfy tax obligations related to vesting restricted stock units.

Director Jarrod M. Patten purchased 100,000 shares of Core Scientific, Inc. common stock at an average price of $3.3222 on March 15, 2024.

Director Todd A. Becker of Core Scientific, Inc. purchased 130,000 shares of common stock on March 15, 2024, at a weighted average price of $3.1551 per share.

Director Eric Stanton Weiss purchased 15,000 shares of Core Scientific, Inc. common stock at an average price of $3.0264 on March 15, 2024.